These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 7243793)
21. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients. Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523 [TBL] [Abstract][Full Text] [Related]
22. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units. Arenas MD; Alvarez-Ude F; Gil MT; Soriano A; Egea JJ; Millán I; Amoedo ML; Muray S; Carretón MA Nephrol Dial Transplant; 2006 Jun; 21(6):1663-8. PubMed ID: 16464885 [TBL] [Abstract][Full Text] [Related]
23. Influence of long-term erythropoietin treatment on plasma levels of calcium-phosphate related hormones in haemodialyzed uraemic patients. Kokot F; Wiecek A; Marcinkowski W; Schmidt-Gayk H; Rudka R; Trembecki J Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():9-16. PubMed ID: 8192535 [TBL] [Abstract][Full Text] [Related]
24. A randomized trial comparing 2.5 mEq/L calcium dialysate and calcitriol to 3.5 mEq/L calcium dialysate in patients on peritoneal dialysis. Banalagay E; Bernardini J; Holley J; Chen T; Piraino B Adv Perit Dial; 1993; 9():280-3. PubMed ID: 8105943 [TBL] [Abstract][Full Text] [Related]
25. Dietary phosphate restriction in dialysis patients: a new approach for the treatment of hyperphosphataemia. Guida B; Piccoli A; Trio R; Laccetti R; Nastasi A; Paglione A; Memoli A; Memoli B Nutr Metab Cardiovasc Dis; 2011 Nov; 21(11):879-84. PubMed ID: 20609572 [TBL] [Abstract][Full Text] [Related]
27. The effects of zero magnesium dialysate and magnesium supplements on ionised calcium concentration in patients on regular dialysis treatment. Breuer J; Moniz C; Baldwin D; Parsons V Nephrol Dial Transplant; 1987; 2(5):347-50. PubMed ID: 3122112 [TBL] [Abstract][Full Text] [Related]
28. Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients. Movilli E; Camerini C; Gaggia P; Poiatti P; Pola A; Viola BF; Zubani R; Jeannin G; Cancarini G Nephrol Dial Transplant; 2011 Dec; 26(12):4032-7. PubMed ID: 21555393 [TBL] [Abstract][Full Text] [Related]
29. Cimetidine-induced PTH variations in uraemic patients evaluated with the aid of antisera against the terminal carboxyl and amino groups of the hormone molecule. Fiore CE; Malatino LS; Tamburino C; Lunetta M; Heynen G Horm Metab Res; 1981 Nov; 13(11):642-5. PubMed ID: 7308973 [TBL] [Abstract][Full Text] [Related]
30. Magnesium, calcium and PTH relationships in dialysis patients after magnesium repletion. Kenny MA; Casillas E; Ahmad S Nephron; 1987; 46(2):199-205. PubMed ID: 3600928 [TBL] [Abstract][Full Text] [Related]
31. Acute effects of propranolol and metoprolol on plasma concentrations of parathyroid hormone and calcitonin in uraemic patients. Coevoet B; Desplan C; Sebert JL; Makdassi R; Gherbrand JD; Tolani M; Calmette C; Moukhtar MS; Fournier A Proc Eur Dial Transplant Assoc; 1979; 16():649-55. PubMed ID: 44916 [TBL] [Abstract][Full Text] [Related]
32. Gastric acid secretion, calcitonin and secondary hyperparathyroidism in uremic patients undergoing regular dialysis therapy (RDT). Antonucci F; Vezzadini P; Cecchettin M; Bonora G; Adami A; Compiano U; Feder G Int J Artif Organs; 1978 Nov; 1(6):260-5. PubMed ID: 738794 [TBL] [Abstract][Full Text] [Related]
34. An assessment of dialysis-associated osteodystrophy in long-term peritoneal dialysis. Hemmeløff Andersen KE; Bengsgaard Pedersen F; Hørder M Nephron; 1982; 30(4):328-32. PubMed ID: 7110463 [TBL] [Abstract][Full Text] [Related]
35. Magnesium hydroxide as a complementary aluminium-free phosphate binder to moderate doses of oral calcium in uraemic patients on chronic haemodialysis: lack of deleterious effect on bone mineralisation. Morinière P; Vinatier I; Westeel PF; Cohemsolal M; Belbrik S; Abdulmassih Z; Hocine C; Marie A; Leflon P; Roche D Nephrol Dial Transplant; 1988; 3(5):651-6. PubMed ID: 3146723 [TBL] [Abstract][Full Text] [Related]
36. Conversion from conventional in-centre thrice-weekly haemodialysis to short daily home haemodialysis ameliorates uremia-associated clinical parameters. Lorenzen JM; Thum T; Eisenbach GM; Haller H; Kielstein JT Int Urol Nephrol; 2012 Jun; 44(3):883-90. PubMed ID: 21359832 [TBL] [Abstract][Full Text] [Related]
37. Magnesium studies in hemodialysis patients before and after treatment with low dialysate magnesium. Nilsson P; Johansson SG; Danielson BG Nephron; 1984; 37(1):25-9. PubMed ID: 6717701 [TBL] [Abstract][Full Text] [Related]
38. Plasma levels of beta-endorphin in uraemic patients during haemodialysis. Caruso U; Lezoche E; Mariani P; Elli M; Tisone G; Cravotto E; Casciani CU Int J Clin Pharmacol Res; 1988; 8(1):17-20. PubMed ID: 2966773 [TBL] [Abstract][Full Text] [Related]
39. Parathyroid hormone and calcitonin secretion in uraemic infants. Zamboni G; Cecchettin M; Zoppi G Eur J Pediatr; 1978 Oct; 129(3):183-90. PubMed ID: 212273 [TBL] [Abstract][Full Text] [Related]